Zacks Research Has Positive Forecast for Clorox Q4 Earnings

The Clorox Company (NYSE:CLX - Free Report) - Equities researchers at Zacks Research increased their Q4 2026 earnings estimates for Clorox in a note issued to investors on Monday, February 17th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $2.18 for the quarter, up from their prior estimate of $1.90. The consensus estimate for Clorox's current full-year earnings is $7.15 per share.

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating analysts' consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the business posted $2.16 EPS.

CLX has been the topic of several other reports. TD Cowen raised shares of Clorox from a "sell" rating to a "hold" rating and raised their price objective for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. DA Davidson dropped their price target on Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 5th. StockNews.com downgraded Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. JPMorgan Chase & Co. lifted their target price on Clorox from $171.00 to $173.00 and gave the company a "neutral" rating in a research note on Tuesday, February 4th. Finally, Wells Fargo & Company boosted their target price on Clorox from $157.00 to $161.00 and gave the company an "equal weight" rating in a report on Tuesday, February 4th. Four research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $158.21.

Clorox Stock Performance

Shares of CLX stock traded up $4.34 during mid-day trading on Thursday, hitting $157.41. 2,375,494 shares of the stock were exchanged, compared to its average volume of 1,353,779. The stock's fifty day simple moving average is $157.87 and its two-hundred day simple moving average is $159.63. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. Clorox has a 12-month low of $127.60 and a 12-month high of $171.37. The stock has a market capitalization of $19.39 billion, a price-to-earnings ratio of 43.01, a P/E/G ratio of 2.58 and a beta of 0.42.

Hedge Funds Weigh In On Clorox

A number of institutional investors and hedge funds have recently made changes to their positions in CLX. Brooklyn Investment Group grew its position in Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after buying an additional 95 shares during the period. Redwood Park Advisors LLC purchased a new stake in shares of Clorox during the 4th quarter worth approximately $26,000. Prospera Private Wealth LLC acquired a new stake in shares of Clorox in the 3rd quarter worth approximately $27,000. Continuum Advisory LLC grew its holdings in shares of Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company's stock worth $30,000 after acquiring an additional 138 shares during the period. Finally, Millstone Evans Group LLC purchased a new position in Clorox in the 4th quarter valued at approximately $31,000. 78.53% of the stock is owned by institutional investors and hedge funds.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.